Funded Biotechnology Startups in India
The 45 rows span April 2020 through November 2025, with Bengaluru and Bangalore collectively accounting for the largest share of companies — among them imm…
The 45 rows span April 2020 through November 2025, with Bengaluru and Bangalore collectively accounting for the largest share of companies — among them immunitoAI (Series A, $6M, November 2025), BUGWORKS Research ($7M, March 2024), and PlasmaGen Biosciences ($27M, December 2023). Pune and Mumbai form a secondary cluster, anchored by BioPrime AgriSolutions ($6M Series A, October 2024) and Ahammune Biosciences ($5M Series A, September 2024).
Seed rounds dominate the 2023–2025 window — BrainSightAI, ErlySign, AltiusHub, and Algorithmic Biologics all closed at that stage within that period. The largest disclosed amounts sit earlier in the timeline: Fingpay raised $267M in April 2020, Molbio Diagnostics closed $83M in September 2022, and MedGenome pulled in $50M the same month. Eyestem's $10M Series B in August 2025 is the largest disclosed round from the past twelve months.
Most recent rounds
45 shownRelated listings
Frequently asked
What are the largest disclosed rounds in this dataset?
The three largest disclosed amounts are Fingpay's $267M raise in April 2020 (Mumbai), Molbio Diagnostics' $83M venture round in September 2022 (Verna, Goa), and MedGenome's $50M venture round in August 2022 (Bangalore). In the more recent window, PlasmaGen Biosciences raised $27M in December 2023 and String Bio closed $20M in July 2022.
Which Indian cities have the highest concentration of funded biotech companies here?
Bengaluru and Bangalore (the same city) account for roughly half the companies shown — including immunitoAI, BUGWORKS Research, PlasmaGen Biosciences, MedGenome, String Bio, and Sea6 Energy. Pune and Mumbai form a secondary cluster, with BioPrime AgriSolutions and Ahammune Biosciences in Pune and Ivory and Piscium Health Sciences in Mumbai. Hyderabad, Ahmedabad, and Noida each contribute two to three companies.
What funding stage are most of these biotech companies raising at?
Seed is the most common labeled stage and dominates the 2023–2025 rows — BrainSightAI ($5M, January 2025), ErlySign ($2M, January 2025), AltiusHub ($2M, September 2024), Algorithmic Biologics ($3M, February 2024), and altM ($4M, September 2023) all closed at Seed. Series A deals are fewer but present: immunitoAI, BioPrime AgriSolutions, Ahammune Biosciences, Mynvax, and OmniBRx Biotechnologies each raised at that stage.
What does 2025 biotech fundraising activity look like in this data?
Seven companies raised in 2025: immunitoAI ($6M Series A, November), Eyestem ($10M Series B, August), QRL Bioscience ($340K Seed, August), Ivory ($1M Seed, April), BrainSightAI ($5M Seed, January), ErlySign ($2M Seed, January), and Prantae Solutions ($580K Seed, January). Eyestem's $10M Series B is the largest among them; the remaining five 2025 raises are all Seed-stage and under $6M.
Are there any companies that raised multiple rounds visible in this data?
BrainSightAI appears twice — a $120K Series Unknown in July 2023 and a $5M Seed round in January 2025, both from Bangalore. The step-up from $120K to $5M within roughly eighteen months points to significant traction between the two raises.
Are funded biotech companies concentrated only in major metros, or do smaller cities appear?
Smaller and non-metro cities are present. Prantae Solutions raised $580K in Bhubaneswar (Odisha), Human Biogenesis closed a pre-seed in Guwahati (Assam), Hummsa Biotech raised $150K in Kolkata, and Biofics raised $1M in Surat. Molbio Diagnostics, one of the larger raises at $83M, is based in Verna, Goa — not a traditional startup hub.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.